Spotlight
AlbionVC: London still outpaces Paris in tech | UKTN
Ed Lascelles, AlbionVC Partner shares insights on the State of European Tech: Why London Still Leads
Startups Magazine | Bigtech won’t ever disrupt the NHS, but it will cause local ripples
Spotlight on AlbionVC’s European Healthtech Market Map in Startups Magazine
UK Innovation Update Report from HSBC Innovation Banking & Dealroom
Ed Lascelles, Partner, comments on the overview of Q1 2025 Venture Capital funding landscape
Ed Lascelles, Partner, speaks with Forbes on the launch of the new Radia 2024 programme
Not Enough Women Are Pitching To VCs: Will An Accelerator Help?
Why investors have a rare opportunity to back startups on their terms
Ed Lascelles, Partner, shares his views with Sifted on the outlook of venture capital investments in 2024.
12 hospital tech startups to watch, according to VCs
Molly Gilmartin, Investor AlbionVC shares her thoughts with Sifted
The outlook for venture capital & tech in 2024
Christoph Ruedig on the BVCA 40th Anniversary Podcast Series
Leigh Brody on the Women in Health Tech Show
Podcast | Women in Health Tech Show with Catherine Davies, Monticle
10 most promising reproductive & fertility tech startups according to VCs
Chirstoph Rueding, Partner on Business Insider
Quell Therapeutics signs a $2bn plus deal with AstraZeneca | FT
UCLTF cell therapy startup Quell Therapeutics signs a $2bn plus deal with AstraZeneca | FT